Six months therapy for tuberculous meningitis

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 9, 2016, Pages

  Jullien, Sophie ^a   Ryan, Hannah ^a   Modi, Manish ^b   Bhatia, Rohit ^c  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ETHIONAMIDE; ISONIAZID; ISONIAZID PLUS RIFAMPICIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RELAPSE; REVIEW; SHORT COURSE THERAPY; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS;

EID: 84984858051     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD012091.pub2     Document Type: Review

References (198)

1. Alarcón F, Escalante L, Pérez Y, Banda H, Chacón G, Dueñas G. Tuberculous meningitis. Short course of chemotherapy. Archives of Neurology 1990;47(12):1313-7.
2. Alvarez-Uria G, Naik PK, Pakam R, Bachu L, Midde M. Natural history and factors associated with early and delayed mortality in HIV-infected patients treated of tuberculosis under directly observed treatment short-course strategy: a prospective cohort study in India. Interdisciplinary Perspectives on Infectious Diseases 2012;2012:502012.
3. Anastasatu C, Anastasatu O, Murgoci G, Dobre M. [The late results of intensive chemotherapy (9 months) in severe forms of tuberculosis in children]. Pneumoftiziologia 1993;42(4):9-12.
4. Biddulph J. Short course chemotherapy for childhood tuberculosis. Paediatric Infectious Diseases Journal 1990;9(11):794-801.
5. Chotmongkol V. Treatment of tuberculous meningitis with 6-month course of chemotherapy. Southeast Asian Journal of Tropical Medicine and Public Health 1991;22(3):372-4.
6. Chotmongkol V, Jitpimolmard S, Thavornpitak Y. Corticosteroid in tuberculous meningitis. Journal of the Medical Association of Thailand [Chotmaihet Thangphaet] 1996;79(2):83-90.
7. Doğanay M, Çalangu S, Turgut H, Bakir M, Aygen B. Treatment of tuberculous meningitis in Turkey. Scandinavian Journal of Infectious Diseases 1989;27(2):135-8.
8. Donald PR, Schoeman JF, van Zyl LE, de Villiers JN, Pretorius M, Springer P. Intensive short course chemotherapy in the management of tuberculous meningitis. International Journal of Tuberculosis and Lung Disease 1998;2(9):704-11.
9. Iype T, Pillai AK, Cherian A, Nujum ZT, Pushpa C, Dae D, et al. Major outcomes of patients with tuberculous meningitis on directly observed thrice a week regime. Annals of Indian Academy of Neurology 2014;17(3):281-6. [DOI: 10.4103/0972-2327.138496]
10. Jacobs RF, Sunakorn P, Chotpitayasunonah T, Pope S, Kelleher K. Intensive short course chemotherapy for tuberculous meningitis. The Pediatric Infectious Disease Journal 1992;11(3):194-8.
11. Lau KK, Yu IT, Chan AC, Wong LK, Tam CM, Sheng B, et al. A registry of tuberculous meningitis in Hong Kong. International Journal of Tuberculosis and Lung Disease 2005;9(12):1391-7.
12. Phuapradit P, Vejjajiva A. Treatment of tuberculous meningitis: role of short-course chemotherapy. The Quarterly Journal of Medicine 1987;62(239):249-58.
13. Ramachandran P, Duraipandian M, Nagarajan M, Prabhakar R, Ramakrishnan CV, Tripathy SP. Three chemotherapy studies of tuberculous meningitis in children. Tubercle 1986;67(1):17-29.
14. Ramachandran P, Duraipandian M, Reetha AM, Mahalakshmi SM, Prabhakar R. Long-term status of children treated for tuberculous meningitis in south India. Tubercle 1989;70(4):235-9.
15. Ramachandran P, Duraipandian M, Reetha AM. A 5 year follow-up study of children treated for tuberculous meningitis with short course chemotherapy. The Indian Journal of Tuberculosis 1997;44:125-7.
16. Ramachandran P, Kripasankar AS, Reetha AM, Mahalakshmi SM, Prabhakar R. Short course chemotherapy study in tuberculous meningitis in children. The Indian Journal of Tuberculosis 1997;44:195-200.
17. Sharma SR, Lynrah KG, Sharma N, Lyngdoh M. Directly observed treatment, short course in tuberculous meningitis: Indian perspective. Annals of Indian Academy of Neurology 2013;16(1):82-4. [DOI: 10.4103/0972-2327.107717]
18. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. The New England of Journal Medicine 2004;351(17):1741-51.
19. Török ME, Nguyen DB, Tran TH, Nguyen TB, Thwaites GE, Hoang TQ, et al. Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents. PLoS One 2011;6(12):e27821. [DOI: 10.1371/journal.pone.0027821]
20. van Toorn R, Schaaf HS, Laubscher JA, van Elsland SL, Donald PR, Schoeman JF. Short intensified treatment in children with drug-susceptible tuberculous meningitis. The Pediatric Infectious Disease Journal 2014;33(3):248-52. [DOI: 10.1097/INF.0000000000000065]
21. Visudhiphan P, Chiemchanya S. Tuberculous meningitis in children: treatment with isoniazid and rifampicin for twelve months. The Journal of Pediatrics 1989;114(5):875-9.
22. Acharya VN, Kudva BT, Retnam VJ, Mehta PJ. Adult tuberculous meningitis: comparative study of different chemotherapeutic regimens. The Journal of the Association of Physicians in India 1985;33(9):583-5.
23. Agrawal M. Prognostic indicators in tubercular meningitis in children. Indian Journal of Tuberculosis 1989;36(3):161-5.
24. Alarcón F, Moreira J, Rivera J, Salinas R, Dueñas G, Van den Ende J. Tuberculous meningitis: do modern diagnostic tools offer better prognosis prediction?. The Indian Journal of Tuberculosis 2013;60(1):5-14.
25. Alvarez-Uria G, Midde M, Pakam R, Naik PK. Initial antituberculous regimen with better drug penetration into cerebrospinal fluid reduces mortality in HIV infected patients with tuberculous meningitis: data from an HIV observational cohort study. Tuberculosis Research and Treatment 2013;2013:242604.
26. Anuradha HK, Garg RK, Agarwal A, Sinha MK, Verma R, Singh MK, et al. Predictors of stroke in patients of tuberculous meningitis and its effect on the outcome. QJM 2010;103(9):671-8.
27. Bandyopadhyay SK, Bandyopadhyay R, Dutta A. Profile of tuberculous meningitis with or without HIV infection and the predicators of adverse outcome. The West Indian Medical Journal 2009;58(6):589-92.
28. Bhagwati SN, George K. Use of intrathecal hyaluronidase in the management of tuberculous meningitis with hydrocephalus. Child's Nervous System 1986;2(1):20-5.
29. Bokade CM, Gulhane RR, Bagul AS, Thakre SB. Acute febrile encephalopathy in children and predictors of mortality. Journal of Clinical and Diagnostic Research 2014;8(8):PC09-11.
30. Cardozo LJ, Raidoo S, Patel BP. Tuberculous meningitis in adult Africans-problems of diagnosis and management. East African Medical Journal 1976;53(3):134-42.
31. Chan KH, Mann KS. Prolonged therapeutic external ventricular drainage: a prospective study. Neurosurgery 1988;23(4):436-8.
32. Chan KH, Cheung RT, Lee R, Mak W, Ho SL. Cerebral infarcts complicating tuberculous meningitis. Cerebrovascular Diseases 2005;19(6):391-5.
33. Chandra B. Some aspects of tuberculous meningitis in Surabaya. Proceedings of the Australian Association of Neurologists 1976;13:73-81.
34. Chugh A, Husain M, Gupta RK, Ojha BK, Chandra A, Rastogi M. Surgical outcome of tuberculous meningitis hydrocephalus treated by endoscopic third ventriculostomy: prognostic factors and postoperative neuroimaging for functional assessment of ventriculostomy. Journal of Neurosurgery. Pediatrics 2009;3(5):371-7.
35. Cotton MF, Donald PR, Schoeman JF, Aalbers C, Van Zyl LE, Lombard C. Plasma arginine vasopressin and the syndrome of inappropriate antidiuretic hormone secretion in tuberculous meningitis. The Pediatric Infectious Disease Journal 1991;10(11):837-42.
36. Cotton MF, Donald PR, Schoeman JF, Van Zyl LE, Aalbers C, Lombard CJ. Raised intracranial pressure, the syndrome of inappropriate antidiuretic hormone secretion, and arginine vasopressin in tuberculous meningitis. Child's Nervous System 1993;9(1):10-5; discussion 15-6.
37. Degefie T. Tuberculous meningitis in a district hospital from Southern Ethiopia. Ethiopian Medical Journal 2003;41(4):311-8.
38. de March-Ayuela P. Trend in tuberculous meningitis in Barcelona in children aged 0-4 years: correlation with the annual risk of tuberculous infection. Tubercle and Lung Disease 1994;75(6):423-8.
39. Dikshit KP, Singh S. Factors influencing prognosis of tuberculous meningitis. Indian Pediatrics 1976;13(8):613-8.
40. Doğanay M, Bakir M, Dökmetaş I. Treatment of tuberculous meningitis in adults with a combination of isoniazid, rifampicin and streptomycin: a prospective study. Scandinavian Journal of Infectious Diseases 1989;21(1):81-5.
41. Donald PR, Burger PJ, Becker WB. Paediatric meningitis in the western Cape. A 3-year hospital-based prospective survey. South African Medical Journal 1986;70(7):391-5.
42. Donald PR, Cotton MF, Hendricks MK, Schaaf HS, de Villiers JN, Willemse TE. Pediatric meningitis in the Western Cape Province of South Africa. Journal of Tropical Pediatrics 1996;42(5):256-61.
43. Eintracht S, Silber E, Sonnenberg P, Koornhof HJ, Saffer D. Analysis of adenosine deaminase isoenzyme-2 (ADA(2)) in cerebrospinal fluid in the diagnosis of tuberculosis meningitis. Journal of Neurology, Neurosurgery, and Psychiatry 2000;69(1):137-8.
44. Elliott AM, Halwiindi B, Hayes RJ, Luo N, Tembo G, Machiels L, et al. The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. The Journal of Tropical Medicine and Hygiene 1993;96(1):1-11.
45. Elliott AM, Halwiindi B, Hayes RJ, Luo N, Mwinga AG, Tembo G, et al. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Transactions of the Royal Society of Tropical Medicine and Hygiene 1995;89(1):78-82.
46. Elliott AM, Halwiindi B, Hayes RJ, Luo N, Mwinga AG, Tembo G, et al. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia. The Journal of Tropical Medicine and Hygiene 1995;98(1):9-21.
47. Erdös Z. [Late results (15-25 years) following therapy of tuberculous meningitis]. Monatsschrift für Kinderheilkunde 1974;122(7):424-5.
48. Escobar JA, Belsey MA, Dueñas A, Medina P. Mortality from tuberculous meningitis reduced by steroid therapy. Pediatrics 1975;56(6):1050-5.
49. Ganiem AR, Parwati I, Wisaksana R, van der Zanden A, van de Beek D, Sturm P, et al. The effect of HIV infection on adult meningitis in Indonesia: a prospective cohort study. AIDS 2009;23(17):2309-16.
50. Garg RK, Sharma R, Kar AM, Kushwaha RA, Singh MK, Shukla R, et al. Neurological complications of miliary tuberculosis. Clinical Neurology and Neurosurgery 2010;112(3):188-92.
51. Girgis NI, Yassin MW, Laughlin LW, Edman DC, Farid Z, Watten RH. Rifampicin in the treatment of tuberculous meningitis. The Journal of Tropical Medicine and Hygiene 1978;81(12):246-7.
52. Girgis NI, Farid Z, Kilpatrick ME, Sultan Y, Mikhail IA. Dexamethasone adjunctive treatment for tuberculous meningitis. The Pediatric Infectious Disease Journal 1991;10(3):179-83.
53. Girgis NI, Sippel JE, Kilpatrick ME, Sanborn WR, Mikhail IA, Cross E, et al. Meningitis and encephalitis at the Abbassia Fever Hospital, Cairo, Egypt, from 1966 to 1989. The American Journal of Tropical Medicine and Hygiene 1993;48(1):97-107.
54. Goyal P, Srivastava C, Ojha BK, Singh SK, Chandra A, Garg RK, et al. A randomized study of ventriculoperitoneal shunt versus endoscopic third ventriculostomy for the management of tubercular meningitis with hydrocephalus. Child's Nervous System 2014;30(5):851-7.
55. Guillen D, Campos P, Hernández H, Chaparro E. Meningoencefalitis tuberculosa en niños: diez años de experiencia en el Hospital Nacional Cayetano Heredia. Revista Médica Herediana 1993;4(4):182-7.
56. Gujjar AR, Srikanth SG, Umamaheshwara Rao GS. HHH regime for arteritis secondary to TB meningitis: a prospective randomized study. Neurocritical Care 2009;10(3):313-7.
57. Gupta A, Garg RK, Singh MK, Verma R, Malhotra HS, Sankhwar SN, et al. Bladder dysfunction and urodynamic study in tuberculous meningitis. Journal of the Neurological Sciences 2013;327(1-2):46-54.
58. Gupta R, Garg RK, Jain A, Malhotra HS, Verma R, Sharma PK. Spinal cord and spinal nerve root involvement (myeloradiculopathy) in tuberculous meningitis. Medicine (Baltimore) 2015;94(3):e404.
59. Heemskerk AD, Bang ND, Mai NTH, Chau TTH, Phu NH, Loc PP, et al. Intensified antituberculosis therapy in adults with tuberculous meningitis. The New England Journal of Medicine 2016;374(2):124-34.
60. Hoose C, Eberhardt K, Hartmann W, Wosniok W. Short- and long-term results of tuberculosis therapy with a fixed combination of isoniazid, prothionamide and diaminodiphenylsulfone combined with rifampicin [Kurz-und Langzeitergebnisse der Tuberkulosetherapie mit einer fixen Kombination aus Isoniazid, Prothionamid und Diaphenylsulfon (IPD) in Verbindung mit Rifampicin]. Pneumologie 1990;44 Suppl 1:458-9.
61. Immanuel C, Acharyulu GS, Kannapiran M, Segaran R, Sarma GR. Acute phase proteins in tuberculous patients. Indian Journal of Chest Diseases & Allied Sciences 1990;32(1):15-23.
62. Irfan A, Qureshi A. Role of ventriculoperitoneal shunt in post-tuberculous meningitic hydrocephalous. The Journal of the Pakistan Medical Association 1995;45(2):37-8.
63. Jain A. Extra pulmonary tuberculosis: a diagnostic dilemma. Indian Journal of Clinical Biochemistry 2011;26(3):269-73.
64. Jain SK, Ordonez A, Kinikar A, Gupte N, Thakar M, Mave V, et al. Pediatric tuberculosis in young children in India: a prospective study. BioMed Research International 2013;2013:783698.
65. Jakka S, Veena S, Rao AR, Eisenhut M. Cerebrospinal fluid adenosine deaminase levels and adverse neurological outcome in pediatric tuberculous meningitis. Infection 2005;33(4):264-6.
66. Jubelt B. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. Current Neurology and Neuroscience Reports 2006;6(6):451-2.
67. Julka RK, Deb M, Patwari AK. Tuberculous meningitis and miliary tuberculosis in children: a clinico-bacteriological profile. Indian Journal of Tuberculosis 1998;45(1):19-22.
68. Kalita J, Misra UK. Motor and somatosensory evoked potentials in tuberculous meningitis: a clinico-radiological correlation. Acta Neurologica Scandinavica 1999;99(4):225-31.
69. Kalita J, Misra UK. Effect of methyl prednisolone on sensory motor functions in tuberculous meningitis. Neurology India 2001;49(3):267-71.
70. Kalita J, Misra UK, Ranjan P. Predictors of long-term neurological sequelae of tuberculous meningitis: a multivariate analysis. European Journal of Neurology 2007;14(1):33-7.
71. Kalita J, Misra UK, Nair PP. Predictors of stroke and its significance in the outcome of tuberculous meningitis. Journal of Stroke and Cerebrovascular Diseases 2009;18(4):251-8.
72. Kalita J, Misra UK, Prasad S, Bhoi SK. Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial. The Journal of Antimicrobial Chemotherapy 2014;69(8):2246-51.
73. Karande S, Gupta V, Kulkarni M, Joshi A. Prognostic clinical variables in childhood tuberculous meningitis: an experience from Mumbai, India. Neurology India 2005;53(2):191-5; discussion 195-6.
74. Karande S, Gupta V, Kulkarni M, Joshi A, Rele M. Tuberculous meningitis and HIV. Indian Journal of Pediatrics 2005;72(9):755-60.
75. Kingkaew N, Sangtong B, Amnuaiphon W, Jongpaibulpatana J, Mankatittham W, Akksilp S, et al. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death. International Journal of Infectious Diseases 2009;13(6):722-9.
76. Koh SB, Kim BJ, Park MH, Yu SW, Park KW, Lee DH. Clinical and laboratory characteristics of cerebral infarction in tuberculous meningitis: a comparative study. Journal of Clinical Neuroscience 2007;14(11):1073-7.
77. Kumarvelu S, Prasad K, Khosla A, Behari M, Ahuja GK. Randomized controlled trial of dexamethasone in tuberculous meningitis. Tubercle and Lung Disease 1994;75(3):203-7.
78. Lamprecht D, Schoeman J, Donald P, Hartzenberg H. Ventriculoperitoneal shunting in childhood tuberculous meningitis. British Journal of Neurosurgery 2001;15(2):119-25.
79. Lardizabal DV, Roxas AA Jr. Dexamethasone as adjunctive therapy in adult patients with probable tuberculosis meningitis stage II and III: an open randomized controlled trial. Philippines Journal of Neurology 1998;4:4-10.
80. Malhotra HS, Garg RK, Singh MK, Agarwal A, Verma R. Corticosteroids (dexamethasone versus intravenous methylprednisolone) in patients with tuberculous meningitis. Annals of Tropical Medicine and Parasitology 2009;103(7):625-34.
81. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Enarson DA, Beyers N. The spectrum of disease in children treated for tuberculosis in a highly endemic area. The International Journal of Tuberculosis and Lung Disease 2006;10(7):732-8.
82. Marais S, Meintjes G, Pepper DJ, Dodd LE, Schutz C, Ismail Z, et al. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clinical Infectious Diseases 2013;56(3):450-60.
83. Maree F, Hesseling AC, Schaaf HS, Marais BJ, Beyers N, van Helden P, et al. Absence of an association between Mycobacterium tuberculosis genotype and clinical features in children with tuberculous meningitis. The Pediatric Infectious Disease Journal 2007;26(1):13-8.
84. Mathew JM, Rajshekhar V, Chandy MJ. Shunt surgery in poor grade patients with tuberculous meningitis and hydrocephalus: effects of response to external ventricular drainage and other variables on long term outcome. Journal of Neurology, Neurosurgery, and Psychiatry 1998;65(1):115-8.
85. Misra UK, Kalita J, Srivastava M, Mandal SK. Prognosis of tuberculous meningitis: a multivariate analysis. Journal of the Neurological Sciences 1996;137(1):57-61.
86. Misra UK, Kalita J, Das BK. Single photon emission computed tomography in tuberculous meningitis. Postgraduate Medical Journal 2000;76(900):642-5.
87. Misra UK, Kalita J, Nair PP. Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. Journal of the Neurological Sciences 2010;293(1-2):12-7.
88. Moreira J, Alarcon F, Bisoffi Z, Rivera J, Salinas R, Menten J, et al. Tuberculous meningitis: does lowering the treatment threshold result in many more treated patients?. Tropical Medicine & International Health 2008;13(1):68-75.
89. Nadvi SS, Nathoo N, Annamalai K, van Dellen JR, Bhigjee AI. Role of cerebrospinal fluid shunting for human immunodeficiency virus-positive patients with tuberculous meningitis and hydrocephalus. Neurosurgery 2000;47(3):644-9; discussion 649-50.
90. Narayanan R. Surgical treatment in tuberculous meningitis. Seara Médica Neurocirúrgica 1982;11:33-9.
91. Panigatti P, Ratageri VH, Shivanand I, Madhu PK, Shepur TA. Profile and outcome of childhood tuberculosis treated with DOTS - an observational study. Indian Journal of Pediatrics 2014;81(1):9-14.
92. Pardasani V, Shukla G, Singh S, Goyal V, Behari M. Abnormal sleep-wake cycles in patients with tuberculous meningitis: a case-control study. Journal of the Neurological Sciences 2008;269(1-2):126-32.
93. Park KH, Lee MS, Lee SO, Choi SH, Kim YS, Woo JH, et al. Kinetics of T-cell-based assays on cerebrospinal fluid and peripheral blood mononuclear cells in patients with tuberculous meningitis. The Korean Journal of Internal Medicine 2014;29(6):793-9.
94. Patwari AK, Aneja S, Chandra D, Singhal PK. Long-term anticonvulsant therapy in tuberculous meningitis--a four-year follow-up. Journal of Tropical Pediatrics 1996;42(2):98-103.
95. Pepper DJ, Marais S, Maartens G, Rebe K, Morroni C, Rangaka MX, et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clinical Infectious Diseases 2009;48(11):e96-107.
96. Phuapradit P, Supmonchai K, Kaojarern S, Mokkhavesa C. The blood/cerebrospinal fluid partitioning of pyrazinamide: a study during the course of treatment of tuberculous meningitis. Journal of Neurology, Neurosurgery, and Psychiatry 1990;53(1):81-2.
97. Porkert MT, Sotir M, Parrott-Moore P, Blumberg HM. Tuberculous meningitis at a large inner-city medical center. The American Journal of the Medical Sciences 1997;313(6):325-31.
98. Radhakrishnan VV, Mathai A. Detection of mycobacterial antigen in cerebrospinal fluid: diagnostic and prognostic significance. Journal of the Neurological Sciences 1990;99(1):93-9.
99. Raghu Raman TS, Gupta RA, Gupta AK, Ravichander B, Sood SL. Tuberculosis in BCG vaccinated and unvaccinated children. Medical Journal Armed Forces India 1997;12(Suppl):68-71.
100. Rahajoe NN, Rahajoe N, Boediman I, Said M, Lazuardi S. The treatment of tuberculosis meningitis in children with a combination of isoniazid rifampicin and streptomycin- preliminary report. Tubercle 1979;60(4):245-50.
101. Rai D, Garg RK, Mahdi AA, Jain A, Verma R, Tripathi AK, et al. Cerebrospinal fluid cytokines and matrix metalloproteinases in human immunodeficiency seropositive and seronegative patients of tuberculous meningitis. Annals of Indian Academy of Neurology 2014;17(2):171-8.
102. Ramzan A, Nayil K, Asimi R, Wani A, Makhdoomi R, Jain A. Childhood tubercular meningitis: an institutional experience and analysis of predictors of outcome. Pediatric Neurology 2013;48(1):30-5.
103. Ranjan P, Kalita J, Misra UK. Serial study of clinical and CT changes in tuberculous meningitis. Neuroradiology 2003;45(5):277-82.
104. Rao GR. Tuberculous mortality in an urban complex in central India: a study of long-term trends. Tubercle 1982;63(3):187-93.
105. Rao TM, Ram R, Swarnalatha G, Sabthosh Pai BH, Ramesh V, Rao CS, et al. Tuberculosis in haemodialysis patients: a single centre experience. Indian Journal of Nephrology 2013;23(5):340-5.
106. Raut T, Garg RK, Jain A, Verma R, Singh MK, Malhotra HS, et al. Hydrocephalus in tuberculous meningitis: incidence, its predictive factors and impact on the prognosis. The Journal of Infection 2013;66(4):330-7.
107. Rojas-Echeverri LA, Soto-Hernández JL, Garza S, Martínez-Zubieta R, Miranda LI, García-Ramos G, et al. Predictive value of digital subtraction angiography in patients with tuberculous meningitis. Neuroradiology 1996;38(1):20-4.
108. Ruslami R, Ganiem AR, Dian S, Apriani L, Achmad TH, van der Ven AJ, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. The Lancet. Infectious Diseases 2013;13(1):27-35.
109. Saleem K, Shah ZH, Siddique K, Abaidullah S, Iqbal M. Predictors of complications of tuberculous meningitis. Pakistan Journal of Medical and Health Sciences 2011;5(2):292-6.
110. Saleem K, Nasrullah M, Shafiq F. Is CT scan poor predictor of complicated tuberculous meningitis?. Pakistan Journal of Medical and Health Sciences 2015;9(1):26-30.
111. Salekeen S, Mahmood K, Naqvi IH, Baig MY, Akhter ST, Abbasi A. Clinical course, complications and predictors of mortality in patients with tuberculous meningitis--an experience of fifty two cases at Civil Hospital Karachi, Pakistan. The Journal of the Pakistan Medical Association 2013;63(5):563-7.
112. Savula MM, Stepanova RV, Piatnochka IT, Shevchuk MP, Rasevich MG. Late observations of patients following tuberculous meningitis. Vrachebnoe Deloe 1975;3:95-8.
113. Schoeman CJ. The epidemiology and outcome of childhood tuberculous meningitis. The Pelonomi Hospital experience. South African Medical Journal 1990;78(5):245-7.
114. Schoeman J, Donald P, van Zyl L, Keet M, Wait J. Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome. Developmental Medicine and Child Neurology 1991;33(5):396-405.
115. Schoeman CJ, Herbst I, Nienkemper DC. The effect of tuberculous meningitis on the cognitive and motor development of children. South African Medical Journal 1997;87(1):70-2.
116. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 1997;99(2):226-31.
117. Schoeman JF, Laubscher JA, Donald PR. Serial lumbar CSF presure measurements and cranial computed tomographic findings in childhood tuberculous meningitits. Child's Nervous System 2000;16(4):203-8; discussion 209.
118. Schoeman JF, Springer P, Ravenscroft A, Donald PR, Bekker LG, van Rensburg AJ, et al. Adjunctive thalidomide therapy of childhood tuberculous meningitis: possible anti-inflammatory role. Journal of Child Neurology 2000;15(8):497-503.
119. Schoeman J, Wait J, Burger M, van Zyl F, Fertig G, van Rensburg AJ, et al. Long-term follow up of childhood tuberculous meningitis. Developmental Medicine and Child Neurology 2002;44(8):522-6.
120. Schoeman JF, Springer P, van Rensburg AJ, Swanevelder S, Hanekom WA, Haslett PA, et al. Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. Journal of Child Neurology 2004;19(4):250-7.
121. Schoeman JF, Janse van Rensburg A, Laubscher JA, Springer P. The role of aspirin in childhood tuberculous meningitis. Journal of Child Neurology 2011;26(8):956-62.
122. Shah I, Meshram L. High dose versus low dose steroids in children with tuberculous meningitis. Journal of Clin Neuroscience 2014;21(5):761-4.
123. Shahbaz N, Hassan Y, Kashif S, Abdullah M. Middle cerebral artery infarction in central nervous system tuberculosis. Pakistan Journal of Medical Sciences 2011;27(4):802-5.
124. Sharma HK, Gupta SK, Sudan SS, Sharma R. Tuberculous meningitis - a clinico-radiological study. JK Science 2013;15(4):198-201.
125. Shor IIa. Work capacity of adolescents and adults with tuberculous meningitis. Problemy Tuberkuleza 1973;51(5):12-4.
126. Simmons CP, Thwaites GE, Quyen NTH, Torok E, Hoang DM, Chau TTH, et al. Pretreatment intracerebral and peripheral blood immune responses in vietnamese adults with tuberculous meningitis: diagnostic value and relationship to disease severity and outcome. Journal of Immunology 2006;176(3):2007-14.
127. Singh BS, Patwari AK, Deb M. Serum sodium and osmolal changes in tuberculous meningitis. Indian Pediatrics 1994;31(11):1345-50.
128. Singh SK, Chandra J, Patwari AK, Aneja S, Anand VK, Dutta AK. Tuberculous meningitis in early infancy. Indian Pediatrics 1998;35(9):887-90.
129. Springer P, Swanevelder S, van Toorn R, van Rensburg AJ, Schoeman J. Cerebral infarction and neurodevelopmental outcome in childhood tuberculous meningitis. European Journal of Paediatric Neurology 2009;13(4):343-9.
130. Swamy R, Acharyulu GS, Duraipandian M, Jawahar MS, Ramachandran R, Sarma GR. Liver function tests during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin & pyrazinamide. Indian Journal of Medical Research 1987;86:549-57.
131. Te Brake L, Dian S, Ganiem AR, Ruesen C, Burger D, Donders R, et al. Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis. International Journal of Antimicrobial Agents 2015;45(5):496-503.
132. Thwaites GE, Chau TT, Caws M, Phu NH, Chuong LV, Sinh DX, et al. Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis. The International Journal of Tuberculosis and Lung Disease 2002;6(10):865-71.
133. Thwaites GE. The diagnosis and pathophysiology of tuberculous meningitis in Vietnamese adults [PhD Thesis]. Ann Arbor (USA): Open University (United Kingdom), 2003.
134. Thwaites GE, Simmons CP, Quyen NTH, Chau TTH, Mai PP, Dung NT, et al. Pathophysiology and prognosis in Vietnamese adults with tuberculous meningitis. The Journal of Infectious Diseases 2003;188(8):1105-15.
135. Thwaites GE, Lan NT, Dung NH, Quy HT, Oanh DT, Thoa NT, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. The Journal of Infectious Diseases 2005;192(1):79-88.
136. Thwaites GE, Duc Bang N, Huy Dung N, Thi Quy H, Thi Tuong Oanh D, Thi Cam Thoa N, et al. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with tuberculous meningitis. The Journal of Infectious Diseases 2005;192(12):2134-41.
137. Thwaites GE, Macmullen-Price J, Tran TH, Pham PM, Nguyen TD, Simmons CP, et al. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. The Lancet. Neurology 2007;6(3):230-6.
138. Thwaites GE, Bhavnani SM, Chau TT, Hammel JP, Török ME, Van Wart SA, et al. Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis. Antimicrobial Agents and Chemotherapy 2011;55(7):3244-53.
139. Torok ME, Chau TT, Mai PP, Phong ND, Dung NT, Chuong LV, et al. Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults. PLoS One 2008;3(3):e1772.
140. Török ME, Yen NT, Chau TT, Mai NT, Phu NH, Mai PP, et al. Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)-associated tuberculous meningitis. Clinical Infectious Diseases 2011;52(11):1374-83.
141. van der Merwe DJ, Andronikou S, Van Toorn R, Pienaar M. Brainstem ischemic lesions on MRI in children with tuberculous meningitis: with diffusion weighted confirmation. Child's Nervous System 2009;25(8):949-54.
142. van Toorn R, Springer P, Laubscher JA, Schoeman JF. Value of different staging systems for predicting neurological outcome in childhood tuberculous meningitis. The International Journal of Tuberculosis and Lung Disease 2012;16(5):628-32.
143. Wait JW, Schoeman JF. Behaviour profiles after tuberculous meningitis. Journal of Trop Pediatrics 2010;56(3):166-71.
144. Caliman-Sturdza OA, Mihalache D, Luca CM, Dorobăţ C. [Clinical aspects of tuberculous meningitis in children]. Revista medico-chirurgicalăč a Societăčţçii de Medici şçi Naturalişçti din Iaşçi 2010;114(3):743-7.
145. Carrasco CE. Nuevas expectativas en el tratamiento y pronóstico de la meningitis tuberculosa. Enfermedades Respiratorias y Cirugía Torácica 1988;4(3):122-3.
146. Das Gupta A, Mania RN, Sahu GN. Treatment of HIV related tuberculosis: experience from a tertiary care hospital in eastern India. Lung India 2005;22(1):5-11.
147. Gunawardhana SA, Somaratne SC, Fernando MA, Gunaratne PS. Tuberculous meningitis in adults: a prospective study at a tertiary referral centre in Sri Lanka. The Ceylon Medical Journal 2013;58(1):21-5.
148. Kilincoglu BF, Dalkilic T, Dincbal MN, Aydin Y. Shunting in hydrocephalus due to tuberculous meningitis. Cases presenting with high cerebrospinal fluid proteins in pediatric age. Journal of Neurosurgical Sciences 2009;53(2):49-53.
149. Mahadevan B, Mahadevan S, Serane V T. Prognostic factors in childhood tuberculous meningitis. The Journal of Tropical Pediatrics 2002;48(6):362-5.
150. Mahajan SK, Sood BR, Machhan P, Gupta D, Sharma A. Tubercular meningitis: a blessing?. Indian Practitioner 2004;57(4):265-6.
151. Nair PK, Bobade O, Kappikar GV. Tuberculous meningitis. Indian Practitioner 2005;58(6):379-81.
152. Rahman ML, Basher A, Rashid M, Islam M, Kuddus R, Arif SM, et al. Central nervous system tuberculosis and adjuvant corticosteroid therapy. Mymensingh Medical Journal 2009;18(1):47-51.
153. Yadav YR, Pande S, Raina VK, Singh M. Lumboperitoneal shunts: review of 409 cases. Neurology India 2004;52(2):188-90.
154. Yadav YR, Parihar V, Agrawal M, Bhatele PR. Endoscopic third ventriculostomy in tubercular meningitis with hydrocephalus. Neurology India 2011;59(6):855-60.
155. Alvarez-Uria G, Pakam R, Midde M, Yalla PS, Naik PK. Adding streptomycin to an intensified regimen for tuberculous meningitis improves survival in HIV-infected patients. Interdisciplinary Perspectives on Infectious Diseases 2015;2015:535134. [DOI: 10.1155/2015/535134]
156. American Thoracic Society, CDC, Infectious Diseases Society of America. Treatment of tuberculosis. Morbidity and Mortality Weekly Report. Recommendations and Reports 2003;52(RR-11):1-77.
157. Conde MB, Efron A, Loredo C, Muzy de Souza GR, Graça NP, Cezar MC, et al. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. The Lancet 2009;373(9670):1183-9. [DOI: 10.1016/S0140-6736(09)60333-0]
158. Working Group of the Clinical Practice Guideline (CPG) on the Diagnosis, Treatment and Prevention of Tuberculosis, Centro Cochrane Iberoamericano (Iberoamerican Cochrane Centre), coordinator Clinical Practice Guideline on the Diagnosis, Treatment and Prevention of Tuberculosis. Quality Plan for the Spanish National Healthcare System of the Spanish Ministry for Health, Social Policy and Equality; Agència d'Informació, Avaluació i Qualitat en Salut de Catalunya (AIAQS - Agency for Information, Evaluation, and Quality in Health of Catalonia); 2009. Clinical Practice Guidelines in the Spanish National Healthcare System: CAHTA n.° 2007/26. http://www.guiasalud.es/GPC/GPC_473_Tuberculosis_AIAQS_compl_en.pdf (accessed 15 May 2015).
159. Department of Health South Africa. National Tuberculosis Management Guidelines 2014. http://www.sahivsoc.org/upload/documents/NTCP_Adult_TB%20Guidelines%2027.5.2014.pdf (accessed 25 July 2015).
160. Donald PR. The chemotherapy of tuberculosis meningitis in children and adults. Tuberculosis 2010;90(6):375-92. [DOI: 10.1016/j.tube.2010.07.003]
161. Donald PR. Cerebrospinal fluid concentrations of antituberculosis agents in adults and children. Tuberculosis 2010;90(5):279-92. [DOI: 10.1016/j.tube.2010.07.002]
162. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomized studies of health care interventions. Journal of Epidemiology and Community Health 1998;52(6):377-84. [DOI: 10.1136/jech.52.6.377]
163. Gordon A, Parsons M. The place of corticosteroids in the management of tuberculous meningitis. British Journal of Hospital Medicine 1972;7:651-5.
164. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383-94.
165. Heemskerk D, Day J, Chau TTH, Dung NH, Yen NTB, Bang ND, et al. Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial. Trials 2011;12:25.
166. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
167. INDEX-TB Guidelines Group. INDEX-TB Guidelines - Guidelines on Extra-Pulmonary Tuberculosis for India. INDEX-TB Guidelines - Guidelines on Extra-Pulmonary Tuberculosis for India. First Edition. New Delhi: World Health Organization Country Office India, 2016.
168. International Union Against Tuberculosis and Lung Disease. Management of Tuberculosis. A Guide to the Essentials of Good Practice. 6th edition, 2010. http://www.theunion.org/what-we-do/publications/technical/english/pub_orange-guide_eng.pdf (accessed 25 July 2015).
169. Jullien S. Length of treatment for TB meningitis: from evidence to recommendation in India [Master dissertation]. Liverpool, UK: Liverpool School of Tropical Medicine, 2015.
170. Marais S, Thwaites G, Schoeman JF, Török ME, Misra UK, Prasad K, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. The Lancet. Infectious Diseases 2010;10(11):803-12.
171. Migliori GB, Zellweger JP, Abubakar I, Ibraim E, Caminero JA, de Vries G, et al. European Union Standards for Tuberculosis Care. European Respiratory Journal 2012;39(4):807-19.
172. Medical Research Council. Streptomycin treatment of tuberculous meningitis. The Lancet 1948;1(6503):582-96.
173. National Institute for Health and Care Excellence. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. NICE guidelines [CG117]. March 2011. http://doctor-ru.org/main/1000/1025.pdf (accessed 1 February 2016).
174. Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database of Systematic Reviews 2016, Issue 4. [DOI: 10.1002/14651858.CD002244.pub4]
175. Principi N, Esposito S. Diagnosis and therapy of tuberculosis meningitis in children. Tuberculosis 2012;92(5):377-83. [DOI: 10.1016/j.tube.2012.05.011]
176. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
177. Revised National Tuberculosis Control Programme. Technical and Operational Guidelines for Tuberculosis Control, 2005. http://www.tbonline.info/media/uploads/documents/technical_&_operational_guidelines_for_tb_control.pdf (accessed 31 July 2015).
178. Revised National Tuberculosis Control Programme. National guidelines on diagnosis and treatment of pediatric tuberculosis. 2012. http://tbcindia.nic.in/WriteReadData/l892s/3175192227Paediatric%20guidelines_New.pdf (accessed 19 August 2015).
179. Sociedad Española de Infectología Pediátrica. Treatment of extrapulmonary tuberculosis and complicated forms of pulmonary tuberculosis [Documento de concenso sobre el tratamiento de la tuberculosis extrapulmonar y formas complicadas de tuberculosis pulmonar]. Anales de Pediatría 2008;69(3):271-8.
180. Sterne JAC, Higgins JPT, Reeves BC on behalf of the development group for ROBINS-I. A tool for assessing Risk Of Bias In Non-randomized Studies of Interventions, Version 7 March 2016. http://www.riskofbias.info (accessed 7 August 2016).
181. TB CARE I. International Standards for Tuberculosis Care. 3rd edition, 2014. https://www.thoracic.org/members/assemblies/assemblies/mtpi/resources/istc-report.pdf (accessed 15 May 2015).
182. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. The Lancet 1974;2(7872):81-4.
183. Thwaites GE, Hien TT. Tuberculous meningitis: many questions, too few answers. The Lancet. Neurology 2005;4(3):160-70.
184. Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J, British Infection Society. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. The Journal of Infection 2009;59(3):167-87. [DOI: 10.1016/j.jinf.2009.06.011]
185. Thwaites GE, van Toorn R, Schoeman J. Tuberculosis meningitis: more questions, still too few answers. The Lancet. Neurology 2013;12(10):999-1010. [DOI: 10.1016/S1474-4422(13)70168-6]
186. Török ME. Tuberculous meningitis: advances in diagnosis and treatment. British Medical Bulletin 2015;113(1):117-31. [DOI: 10.1093/bmb/Idv003]
187. van Loenhout-Rooyackers JH, Keyser A, Laheij RJF, Verbeek ALM, van der Meer JWM. Tuberculosis meningitis: is a 6-month treatment regimen sufficient?. International Journal of Tuberculosis and Lung Disease 2001;5(11):1028-35.
188. World Health Organization. Treatment of tuberculosis guidelines. 4th edition, 2010. http://apps.who.int/iris/bitstream/10665/44165/1/9789241547833_eng.pdf?ua=1&ua=1 (accessed 15 May 2015).
189. World Health Organization. Rapid advice. Treatment of tuberculosis in children. 2010. http://apps.who.int/iris/bitstream/10665/44444/1/9789241500449_eng.pdf (accessed 26 May 2015).
190. World Health Organization. Definitions and reporting framework for tuberculosis - 2013 revision (updated December 2014). http://apps.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf (accessed 01 February 2016).
191. World Health Organization. Global Tuberculosis Report 2014. http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf (accessed 21 September 2015).
192. World Health Organization. Global Tuberculosis Report 2015. http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=1 (accessed 22 March 2016).
193. Woodfield J, Argent A. Evidence behind the WHO guidelines: hospital care for children: what is the most appropriate anti-microbial treatment for tuberculous meningitis?. Journal of Tropical Pediatrics 2008;54(4):220-4. [DOI: 10.1093/tropej/fmn063]
194. Yaramiş A, Gurkan F, Elevli M, Söker M, Haspolat K, Kirbaş G, et al. Central nervous system tuberculosis in children: a review of 214 cases. Pediatrics 1998;102(5):E49.
195. Ziganshina LE, Titarenko AF, Davies GR. Fluoroquinolones for treating tuberculosis (presumed drug-sensitive). Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD004795.pub4]
196. Zumla AI, Gillespie SH, Hoelscher M, Philips PPJ, Cole ST, Abubakar I, et al. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. The Lancet. Infectious Diseases 2014;14(4):327-40. [DOI: 10.1016/S1473-3099(13)70328-1]
197. Zumla A, Chakaya J, Centis R, D'Ambrosio L, Mwaba P, Bates M, et al. Tuberculosis treatment and management-an update on treatment regimens, trials, new drugs, and adjunct therapies. The Lancet. Respiratory medicine 2015;3(3):220-34. [DOI: 10.1016/S2213-2600(15)00063-6]
198. Jullien S, Ryan H, Modi M, Bhatia R. Short-course versus prolonged-course antituberculous treatment in tuberculous meningitis. Cochrane Database of Systematic Reviews 2016, Issue 2. [DOI: 10.1002/14651858.CD012091]